# Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Study · id `cardio:ct-nct05478304` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05478304](<https://clinicaltrials.gov/study/NCT05478304>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05478304

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 6573 participants.

## Technical summary

Registry record NCT05478304. Randomized; triple masking; primary purpose treatment. Start 2023-01-25 (actual); primary completion 2031-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 6573 participants (enrolled count; ClinicalTrials.gov record NCT05478304, source copy `cardio:ctgov-nct05478304-2026-11-04`, retrieved 2026-11-18)
- Started: 2023-01-25 (actual) (ClinicalTrials.gov record NCT05478304, source copy `cardio:ctgov-nct05478304-2026-11-04`, retrieved 2026-11-18)
- Primary completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT05478304, source copy `cardio:ctgov-nct05478304-2026-11-04`, retrieved 2026-11-18)
- Completion: 2032-04 (anticipated) (ClinicalTrials.gov record NCT05478304, source copy `cardio:ctgov-nct05478304-2026-11-04`, retrieved 2026-11-18)
- Countries: United States; Australia; Austria; Belgium; Canada; Czechia; Germany; New Zealand; Spain; United Kingdom (ClinicalTrials.gov record NCT05478304, source copy `cardio:ctgov-nct05478304-2026-11-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05478304-2026-11-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
- Acronym: LeAAPS
- Condition: Ischemic Stroke
- Condition: Systemic Embolism
- Intervention (Device): AtriClip LAA Exclusion System
- Lead sponsor: AtriCure, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Population Health Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: AtriCure, Inc. (`cardio:org-atricure-inc`)
- Registry lists this organization as a collaborator: Population Health Research Institute (`cardio:org-population-health-research-institute`)

## Provenance

Content hash: e11c82ffdbc9405e53ea2ff1930ef7424f9481bb0928dea10ca8c192580645dd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
